CompletedNot Applicable

Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses

Germany176 participantsStarted 2017-02-21

Plain-language summary

This randomized multi-center study is intended to compare different coatings on stents for treatment of lesions of the above-the-knee femoropopliteal artery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * One de novo or restenosed artherosclerotic lesion with ≥ 50% diameter stenosis * Symptoms of peripheral arterial disease (Rutherford 2-4) Exclusion Criteria: * Pregnant, breastfeeding, or planning to become pregnant in the next 5 years * Less than 18 years old * Medical condition or disorder that would limit life expectancy to less than 12 months or that may cause noncompliance with the protocol or confound the data analysis * Previous stent in the study vessel

What they're measuring

The percent diameter stenosis within the study lesion evaluated by conventional angiography.

Timeframe: 6 months

Trial details

NCT IDNCT02936622

SponsorCook Group Incorporated

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-04-23

View on ClinicalTrials.gov More Peripheral Arterial Disease (PAD) trials